SCHEMBL31240646

SCHEMBL31240646

CS(=O)(=O)Nc1cccc(-c2cc3c(Cl)ccnc3[nH]2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHUK O15111 3/20 0.62
▸ INSR P06213 2/20 0.62
▸ MAPK8 P45983 2/20 0.62
▸ CAMKK2 Q96RR4 2/20 0.62
▸ KIT P10721 4/20 0.55
▸ CYP1A2 P05177 6/20 0.49
▸ CYP3A4 P08684 6/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ NPY5R Q15761 1/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ TP53 P04637 2/20 0.48
▸ IKBKB O14920 1/20 0.46
▸ CYP2D6 P10635 3/20 0.46
▸ USP2 O75604 2/20 0.46
▸ CLK4 Q9HAZ1 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ TSHR P16473 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240753 0.84 KIT (0.50) CHUKINSRMAPK8CAMKK2KIT
SCHEMBL31240667 0.84 CDK9 (0.46) CHUKINSRMAPK8CAMKK2KIT
SCHEMBL31240593 0.77 CDC7 (0.59) CYP1A2ALDH1A1LMNASMN1; SMN2CYP2C19
SCHEMBL16041244 0.77 CDC7 (0.59) CYP1A2ALDH1A1LMNASMN1; SMN2CYP2C19
SCHEMBL4764919 0.77 BRAF (0.58) CHUKINSRMAPK8CAMKK2KIT
SCHEMBL31240751 0.77 CCNB2 (0.61) CDC7PIM1CDK9
SCHEMBL31240688 0.77 CDK9 (0.50) CDC7PIM1CDK9MEN1
SCHEMBL2444894 0.76 CCNB2 (0.64) CHUKNPY5RIKBKBCLK4CDC7
SCHEMBL31240562 0.76 CDK9 (0.47) CDC7PIM1CDK9
SCHEMBL31240729 0.75 CD74 (0.50) CHUKINSRMAPK8CAMKK2CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback